HONG KONG: Hong Kong-based multinational Li and Fung Ltd is considering options for its Asian healthcare arm, including a sale, that could value the business at up to US$500mil (RM2.17bil), two people with direct knowledge of the matter say.
The sources said Li and Fung has asked banks to pitch options for IDS Medical Systems Group (idsMED), which provides integrated solutions for medical equipment, supplies and services. According to the sources, discussions are still in the early stages and no decision has been made.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
